Form 4 Tracker
MapLight Therapeutics, Inc.
MPLT

55 insider filings · Latest: Aug 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 3, 2026Aug 5 12:39 AMJames Woodruff LillieChief Scientific Officer
Sale
22,082$12.54$276.9K202,380(D)

View →

Aug 3, 2026Aug 3 8:00 PMLillie James Woodruff
Proposed Sale
22,082$13.02$287.5K

View →

Jul 30, 2026Jul 31 1:08 AMNovo Holdings A/S
Proposed Sale
1,600,000$15.02$24.0M

View →

Jul 30, 2026Jul 30 10:39 PMCatalyst4, Inc.10% Owner
Purchase
1,000,000$13.00$13.0M20,906,689(I)

View →

Jul 29, 2026Jul 30 10:39 PMCatalyst4, Inc.10% Owner
Purchase
3,000$12.63$37.9K19,906,689(I)

View →

Jul 28, 2026Jul 30 10:39 PMCatalyst4, Inc.10% Owner
Purchase
206,225$11.04$2.3M19,903,689(I)

View →

Jul 28, 2026Jul 29 1:14 AMTroy CoxDirector
Purchase
15,620$9.52$148.7K15,620(I)

View →

Jul 17, 2026Jul 20 10:00 AMJonathan GillisCAO and Interim CFO
Sale
18,469$37.60$694.5K144,240(D)

View →

Jul 16, 2026Jul 20 10:00 AMJonathan GillisCAO and Interim CFO
Sale
8,455$36.80$311.1K162,709(D)

View →

Jul 15, 2026Jul 20 10:00 AMJonathan GillisCAO and Interim CFO
Sale
10,055$36.51$367.1K171,164(D)

View →

Jul 17, 2026Jul 20 10:00 AMAnatol KreitzerChief Discovery Officer
Sale
17,173$37.60$645.7K174,906(D)

View →

Jul 16, 2026Jul 20 10:00 AMAnatol KreitzerChief Discovery Officer
Sale
9,056$36.80$333.2K192,079(D)

View →

Jul 15, 2026Jul 20 10:00 AMAnatol KreitzerChief Discovery Officer
Sale
10,055$36.49$366.9K201,135(D)

View →

Jul 17, 2026Jul 18 1:46 AMChristopher A. KroegerDirector, Chief Executive Officer
Sale
16,779$37.90$635.9K1,246,455(D)

View →

Jul 16, 2026Jul 18 1:46 AMChristopher A. KroegerDirector, Chief Executive Officer
Sale
69,082$36.79$2.5M1,263,234(D)

View →

Jul 15, 2026Jul 18 1:46 AMChristopher A. KroegerDirector, Chief Executive Officer
Sale
61,778$36.69$2.3M1,332,316(D)

View →

Jul 17, 2026Jul 18 1:45 AMJames Woodruff LillieChief Scientific Officer
Sale
2,077$37.90$78.7K224,462(D)

View →

Jul 16, 2026Jul 18 1:45 AMJames Woodruff LillieChief Scientific Officer
Sale
8,547$36.79$314.4K226,539(D)

View →

Jul 15, 2026Jul 18 1:45 AMJames Woodruff LillieChief Scientific Officer
Sale
7,643$36.70$280.5K235,086(D)

View →

Jul 17, 2026Jul 18 1:44 AMKristopher HansonGeneral Counsel
Sale
1,130$37.90$42.8K145,823(D)

View →

Page 1 of 6

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 23, 2026Jun 25 10:04 PMTroy CoxDirector
Grant/Award
29,804$28.6429,804(D)

View →

Jun 23, 2026Jun 25 10:01 PMMartin BablerDirector
Grant/Award
29,804$28.6429,804(D)

View →

Jun 23, 2026Jun 25 9:59 PMTimothy John GarnettDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:57 PMNanna Liebach LuneborgDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:54 PMGeorge PavlovDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:52 PMMaria C WalkerDirector
Grant/Award
14,902$28.6414,902(D)

View →

Feb 5, 2026Feb 9 10:50 PMJonathan GillisCAAO and PAO
Grant/Award
24,455$15.7024,455(D)

View →

Feb 5, 2026Feb 9 10:50 PMVishwas SetiaChief Financial Officer
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMJames Woodruff LillieChief Scientific Officer
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMAnatol KreitzerChief Discovery Officer
Grant/Award
24,455$15.7024,455(D)

View →

Feb 5, 2026Feb 9 10:50 PMKristopher HansonGeneral Counsel
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMErin Pennock FoffChief Medical Officer
Grant/Award
54,240$15.7054,240(D)

View →

Feb 5, 2026Feb 9 10:50 PMChristopher A. KroegerDirector, Chief Executive Officer
Grant/Award
93,955$15.7093,955(D)

View →